In conclusion, we defined high GTSE1 expression as a worse prognostic trigger for lung cancer patients and reported that GTSE1 acts as an oncogene by activating AKT/mTOR signaling in the lung cancer. The gene discussed is MTOR; the disease is lung cancer.